Caitlin Cronin

Stock Analyst at Canaccord Genuity

(0.52)
# 2536
Out of 5,370 analysts
29
Total ratings
43.75%
Success rate
-2.42%
Average return
12 Stocks
Name Action PT Current % Upside Ratings Updated
ENOV Enovis
Maintains: Buy
75 70
32.27 116.92% 2 May 14, 2025
AXGN Axogen
Maintains: Buy
26 24
9.74 146.41% 6 May 13, 2025
SNN Smith & Nephew
Maintains: Hold
27 28
29.27 -4.34% 2 May 1, 2025
INMD InMode
Maintains: Hold
17 15
13.42 11.77% 3 Apr 29, 2025
TELA TELA Bio
Maintains: Buy
12 7
1.62 332.1% 4 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 15
6.57 128.31% 1 Mar 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
64 67
41.62 60.98% 3 Feb 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
3 4
3.25 23.08% 2 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 20
10.98 82.15% 3 Aug 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
130
92.12 41.12% 1 Feb 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
79
58.89 34.15% 1 Feb 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
270 12
8.18 46.7% 1 Nov 14, 2023